|
Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy |
|
|
|
Titel: |
Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy |
Auteur: |
Passaro, A. Mancuso, P. Gandini, S. Spitaleri, G. Labanca, V. Guerini-Rocco, E. Barberis, M. Catania, C. Del Signore, E. de Marinis, F. Bertolini, F. |
Verschenen in: |
Clinical and translational oncology |
Paginering: |
Jaargang 22 () nr. 4 pagina's 603-611 |
Jaar: |
2019-06-28 |
Inhoud: |
|
Uitgever: |
Springer International Publishing, Cham |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|